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Background: Previous studies find that both schizophrenia and mood disorder risk alleles contribute 
to adult depression and anxiety. Emotional problems (depression or anxiety) begin in childhood and 
show strong continuities into adult-life; this suggests that symptoms are the manifestation of the same 
underlying liability across different ages. However, other findings suggest there are developmental 
differences in the etiology of emotional problems at different ages. To our knowledge, no study has 
prospectively examined the impact of psychiatric risk alleles on emotional problems at different ages
in the same individuals.
Methods: Data were analyzed using regression-based analyses in a prospective, population-based UK 
cohort (the National Child Development Study). Schizophrenia and major depressive disorder (MDD) 
polygenic risk scores (PRS) were derived from published Psychiatric Genomics Consortium genome-
wide association studies. Emotional problems were assessed prospectively at six time-points from age 
7 to 42 years.
Results: Schizophrenia PRS were associated with emotional problems from childhood (age 7 
OR=1.09 (1.03-1.15), p=0.003) to mid-life (age 42 OR=1.10 (1.05-1.17), p<0.001), while MDD PRS 
were associated with emotional problems only in adulthood (age 42 OR=1.06 (1.00-1.11), p=0.034; 
age 7 OR=1.03 (0.98-1.09), p=0.228).  
Conclusions: Our prospective investigation suggests that early (childhood) emotional problems in the 
general population share genetic risk with schizophrenia, while later (adult) emotional problems also 
share genetic risk with MDD. The results suggest that the genetic architecture of depression/anxiety is 
not static across development. 
Key words: genetic; polygenic risk scores; schizophrenia; depression; anxiety; emotional problems; 
longitudinal; NCDS 
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The impact of schizophrenia and mood disorder risk alleles on emotional problems: 
investigating change from childhood to middle age 
Emotional problems - depression and anxiety - are the most common adult mental health problems 
(Kessler et al., 2005). When defined as categorical diagnoses, they affect around 16% of the 
population at any one time and are a leading cause of disability (McManus et al., 2009, Murray and 
Lopez, 1997, Murray and Lopez, 2013). Emotional problems present throughout the life-span but 
often are considered as originating in childhood and adolescence (Rutter et al., 2006). Findings from 
longitudinal, high-risk and cross-generational studies show strong links between emotional problems 
in childhood/adolescence and adult life (Maughan and Collishaw, 2015, Rutter et al., 2006, Thapar et 
al., 2012). This has led to the prevailing belief that symptoms index the same underlying liability 
across different ages, regardless of whether they manifest in childhood, adolescence or adulthood. 
However, there are some observations that argue against a developmental continuity hypothesis that 
assumes that the same liability underlies the manifestation of symptoms at different ages. 
Epidemiological research suggests that gender ratios of emotional problems differ across the lifespan 
– in childhood, males are as commonly affected as females but an increasingly strong female 
preponderance emerges in adolescence (Beesdo et al., 2009, Green et al., 2005, Kessler et al., 2001, 
Lewinsohn et al., 1998). This raises the possibility of etiological differences between very early 
emotional problems and those that emerge later. There is also evidence that treatment response may 
differ with age, with some types of effective adult antidepressant medications having either no 
therapeutic effects in childhood and adolescence (e.g. tricyclics) or being less effective in this age 
group: the reasons for this remain a puzzle (Brent and Maalouf, 2015, Hazell et al., 1995, Thapar et 
al., 2012). 
Molecular genetic studies may provide insight into etiological differences between emotional 
problems at different stages of the life-span. For complex disorders, large genome-wide association 
studies of patients and controls suggest that individual common risk alleles have small effects. 
However, findings from these studies can be used to generate an individual’s estimated total burden of 
risk alleles (indexed by polygenic risk scores, PRS) for a particular disorder (Cross-Disorder Group of 
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the Psychiatric Genomics Consortium, 2013). These scores, although weakly predictive at present, do 
provide a biological indicator of genetic loading for an illness (see Kendler, 2016). Previous studies 
find that both schizophrenia and mood disorder risk alleles contribute to adult major depressive 
disorder (MDD) and anxiety disorders (Cross-Disorder Group of the Psychiatric Genomics 
Consortium, 2013, Docherty et al., 2017, Jones et al., 2016, Okbay et al., 2016, Verduijn et al., 2016)
and that schizophrenia PRS contribute to childhood emotional problems (Nivard et al., 2017, Riglin et 
al., 2017a). However, findings from a recent genetic study of adult major depressive disorder
suggested a heterogeneous genetic architecture that was indexed by age-of-onset (Power et al., 2017); 
while a genome-wide significant locus was identified to be specifically associated with “later-onset” 
depression (after a median age of 27 years), depression that began earlier was associated with 
schizophrenia risk alleles. To date, as far as we know, there have been no systematic attempts at 
examining whether the molecular genetic architecture of emotional problems in the general 
population changes with age – from childhood to adulthood. A prospective cohort design would 
enable investigation of the same individuals at different ages.
We set out to investigate the contribution of schizophrenia and MDD risk alleles to emotional 
problems during childhood, adolescence, young adulthood and mid-life that were assessed in a 
longitudinal UK population-based cohort – the National Child Development Study. Based on previous 
cross-sectional findings for patients with MDD (Power et al., 2017), we hypothesised that “early” 
emotional problems in childhood and adolescence would be indexed by schizophrenia risk alleles 
identified in GWA case-control studies of patients with schizophrenia but that “later” emotional 
problems in adulthood would be predicted by major depressive disorder (MDD) risk alleles.  
Methods 
Sample 
The National Child Development Study (NCDS) is a well-established prospective UK birth cohort. 
The study recruited 18,558 children from England, Wales and Scotland born during one week in 
1958. In 2002, when participants were aged 44 years, a biomedical survey was conducted which 
included the collection of genetic data. Participants who took part in the biomedical survey (N=9377) 
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were broadly representative of the full cohort with regards to childhood social class, maternal and 
physical characteristics and key adult characteristics although nonparticipation (and dropout across 
the study follow-up periods more broadly) was associated with being born to a single parent family, 
early social care, non-white ethnicity and childhood cognitive and behavioural problems (Atherton et 
al., 2008). Participants for the present study are those with genotype data: N=5,257 individuals 
following quality control (see below). These individuals were broadly representative of the full 
biomedical participants in terms of childhood sociodemographic factors and emotional problems, but 
had lower levels of emotional problems in adulthood than those without genotype data 
(Supplementary Table S1). Full details of the study are described elsewhere (Power and Elliott, 2006). 
Ethical approval for the biomedical survey from which genetic data were available was obtained from 
the South East Multicentre Research Ethics Committee. 
Emotional problems 
Emotional problems were assessed six times: in childhood (age 7 years), late childhood (age 11), 
adolescence (age 16 years), young adulthood (age 23 years), adulthood (age 33 years), and mid-life 
(age 42 years).  
In childhood, late childhood and adolescence, data were collected using parent-reports of two 
depression/anxiety items (miserable or tearful; worries about many things) from an abbreviated 
version of the Rutter A scale for children (Rutter et al., 1970) (individuals item range 0-2; possible 
range for total score 0-4). At ages 7 and 11 years this used ‘modified’ response options (never, 
sometimes, frequently) while at age 16 years this used the ‘standard’ Rutter response options (doesn’t 
apply, applies somewhat, certainly applies). In adulthood (including mid-life), data were collected 
using self-reports of eleven depression/anxiety items from the Malaise Inventory (Rodgers et al., 
1999) (individuals item response yes/no; possible range for total score 0-11; individuals items are 
included in Supplementary Table S2).  
The primary outcome measures were total Rutter A scale emotional scores and total 
depression/anxiety Malaise scores. Sensitivity analyses were conducted using outcomes defined by 
the total score for a “restricted” set of two items that were common to the Rutter A and Malaise scales 
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(miserable, worries; see Supplementary Table S3). For descriptive purposes, emotional symptom 
scores were also dichotomised whereby the top 10% of individuals were considered to have emotional 
problems; these were used to generate groups based on the presence of ‘early’ symptoms (age 7 or 11 
years) and ‘later’ symptoms (age 33 or 42 years).
Polygenic risk scores 
Polygenic risk scores (PRS) were generated as the weighted mean number of disorder risk alleles in 
approximate linkage equilibrium (R2<0·25), using standard procedures (Cross-Disorder Group of the 
Psychiatric Genomics Consortium, 2013); full details of these methods are given elsewhere (Riglin et 
al., 2017b). Schizophrenia and MDD risk alleles were identified as those associated with case status 
in the Psychiatric Genetic Consortium (PGC) analyses (schizophrenia 35,476 cases and 46,839 
controls; MDD 9,240 cases and 9,519 controls) at a threshold of p<0.05 for schizophrenia and p<0.5 
MDD. For schizophrenia, the threshold was both the modal and median threshold that in PRS 
analyses of the samples contributing to that meta-analysis, captured the maximum phenotype variance
(Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). For MDD, this 
threshold maximally captures phenotypic variance in the MDD GWAS study (Ripke et al., 2013).
Associations across a range of p-thresholds are shown in Supplementary Figure S1. Individuals were 
genotyped at age 44 years; roughly half of the sample on the Infinium HumanHap 550K v3 and half 
on the Illumina 1.2M (N=2,519 and 2,738 respectively). PRS were derived from the overlapping
510,982 single nucleotide polymorphisms (SNPs) which passed quality control. In line with previous 
work, platform and ten population stratification principal components were included as covariates in 
all analyses (Riglin et al., 2017b). Individuals with genetic data were included in this study: N=5,257.
Statistical analyses 
Associations between schizophrenia PRS and MDD PRS and emotional problems at each age were 
primarily investigated using ordinal regressions in Stata version 13 (StataCorp, 2013). All analyses 
controlled for sex. Sensitivity checks were conducted to investigate alternative explanations for age 
differences in associations between emotional problems and PRS findings. First, we assessed whether 
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any age-related differences in association were driven by measurement differences. We generated 
outcomes derived from the “restricted set” of two items (miserable; worries) which were the same 
across the child and adult scales - see Supplementary Table S3 for details). Second, to check whether 
associations were driven by persistent vs. later-onset symptoms, we generated four groups: those with 
elevated symptoms (top decile) in childhood only (age 7 or 11 years, but not later: N=269), in adult 
life only (ages 33 or 42, but not earlier: N=168) and those who showed persistently elevated scores 
(age 7 or 11 and age 33 or 42: N=145). These were compared to those that never had elevated levels 
of symptoms (age 7, 11, 16, 23, 33, or 42: N=1604). Finally, the potential impact of missing data 
(which ranged from 3.5-23.3%) was investigated by running analyses using nonresponse weights (see 
Supplementary Material). 
Results 
Frequencies for total emotional problem scores at each age are shown in Figure 1; emotional problems 
were associated with female gender at every age (see Figure 1). Correlations between measures are 
given in Supplementary Table S4.  
Associations with schizophrenia and MDD risk alleles 
Associations between PRS and emotional problems are shown in Table 1 and Figure 2. Schizophrenia 
PRS were associated with emotional problems from childhood to mid-life (ages 7, 16, 23, 33 and 42 
years – although not at age 11 years), while MDD PRS were associated with emotional problems only 
in adulthood (including mid-life: ages 33 and 42 years).  
Sensitivity checks 
Running analyses on the restricted set of depression/anxiety items found associations between 
schizophrenia PRS and emotional problems from childhood to mid-life and between MDD PRS and 
emotional problems in adulthood only, suggesting age-related differences in associations between 
PRS and emotional problems are not driven by item differences between the child and adult scales 
(see Supplementary Table S5). Frequencies for the restricted set of total emotional problems are 
shown in Supplementary Figure S2.
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Assessing persistent and later-onset emotional problems found no clear pattern of associations 
between PRS and specific age-at-onset/persistence groups, although there was some indication that 
associations between schizophrenia PRS and childhood emotional problems may be driven by 
persistent problems and that associations between MDD PRS and adult emotional problems may be 
driven by later-onset emotional problems. However these analyses were underpowered due to small 
sample sizes (see Supplementary Figure S3). 
Investigating the potential impact of missing data using nonresponse weights did not change the 
pattern of associations (Supplementary Table S6). 
Discussion 
We set out to investigate the contribution of psychiatric disorder risk alleles to emotional problems 
across childhood, adolescence, young adulthood and mid-life. Similar associations across the life span 
would suggest that the same liability underlies the manifestation of emotional problems at different 
ages – as implied by strong links between emotional problems in childhood/adolescence and 
depression/anxiety in adult life (Maughan and Collishaw, 2015, Rutter et al., 2006, Thapar et al., 
2012). Our findings suggest that associations with mood disorder and schizophrenia risk alleles differ 
across ages, implying possible age-related heterogeneity in the genetic architecture of emotional 
problems in the general population. Specifically, in keeping with a previous study of patients with 
MDD, schizophrenia risk alleles – indexed by PRS – were associated with emotional problems across 
the life span from childhood (age 7 years) to mid-life (age 42 years) (apart from age 11 years), while 
MDD risk alleles were associated with emotional problems in adulthood (ages 33 and 42) but not in 
younger individuals. 
Our hypothesis that schizophrenia PRS would impact ‘early’ emotional problems in childhood 
and adolescence was driven by recent genetic work which found “earlier-onset” depression (before a 
median age of 27 years) had greater genetic overlap with schizophrenia compared to “later-onset” 
depression (Power et al., 2017). This is the third sample in which associations between schizophrenia 
risk alleles and anxiety symptoms/emotional problems have been observed during 
childhood/adolescence (Jones et al., 2016, Nivard et al., 2017, Riglin et al., 2017a). Sensitivity checks 
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suggested that associations between schizophrenia PRS and emotional problems in childhood might 
be driven, at least partly, by early-onset, persistent emotional problems which are still present in 
adulthood – although this hypothesis requires replication.  
Our second hypothesis, that MDD risk alleles would impact ‘later’ emotional problems, was 
supported by findings that MDD PRS were associated with emotional problems in adulthood (ages 33 
and 42) but not before – during childhood, adolescence or early twenties (ages 7, 11, 16 and 23). The 
findings suggest that later emotional problems are genetically more similar to MDD than are early or 
childhood/adolescent onset emotional problems. Our finding that adult emotional problems are 
associated with both MDD and schizophrenia PRS is consistent with previous work using similar 
outcomes in population samples (Gale et al., 2016, Hyde et al., 2016, Okbay et al., 2016). Our results 
at age 23 years were similar to those found in adolescence and we observed  association with MDD 
PRS only after the age of 30. Similarly, stratification by age-at-onset of a GWAS of patients with 
MDD suggested “adult-onset” MDD emerged around 27 years of age. These findings suggest that 
whether focusing on patients or the general population, the early twenties might not be as clearly 
distinct from adolescence and as similar to later adulthood as assumed by the cut-point of age 18 years 
that is typically used to compare “children” and “adults” and divide clinical services.   
The present study is the first, to our knowledge, to examine prospectively the impact of 
schizophrenia and MDD risk alleles on emotional problems at different ages in the same individuals. 
This work adds to findings from MDD patient studies in suggesting that early-onset emotional 
problems may share more genetic risk with schizophrenia, while adult emotional problems share 
genetic risk with both schizophrenia and MDD. This could be viewed as arguing against a 
straightforward developmental continuity hypothesis, at least in terms of genetic architecture. The 
findings instead suggest the possibility that different liabilities may underlie the manifestation of 
symptoms at different ages, which may explain why gender ratios and treatment responses for 
depression have been found to differ by age and developmental stage (Brent and Maalouf, 2015, 
Hazell et al., 1995, Thapar et al., 2012). This suggestion – that genetic architecture is not static across 
development – would also have implications for initiatives such as R-doc as it implies that the 
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biological correlates of the same symptoms or psychiatric construct could be dissimilar at different 
ages (Cuthbert and Insel, 2013, Insel et al., 2010). 
This study should be considered in light of a number of limitations. One issue of particular 
importance is the use of different measures and reporters of emotional problems. As is typical of 
longitudinal studies, different measures and informants were used in childhood and adult life, which 
creates challenges for longitudinal research. To assess developmental continuities and change 
robustly, the use of the same measures (with the same informant, wording, response options etc.) is 
required across each wave of data collection (Collishaw et al., 2009, Goodman et al., 2007). This is an 
issue for historical cohorts such as NCDS and we urge cohort investigators with ongoing data 
collection in different countries to give this serious consideration, especially when participants are 
transitioning between childhood/adulthood. While we were able to observe age-related differences in 
associations when using the same measure and reporter (MDD PRS were associated with Malaise 
scores at ages 33 and 42 but not at age 23 years) and sensitivity analyses restricting our outcomes to 
the same depression/anxiety items at each age revealed a similar pattern of results, we cannot rule out 
that some differences are driven by measurement differences rather than age.  
Additional limitations include that, while our sample benefits from prospective data collected 
from childhood to mid-life, it does not yet cover the entire life span: emotional problems with onset in 
older age may differ from those with earlier onset (Alexopoulos, 2005). Further, our sample is a 
longitudinal study that suffers from non-random attrition: individuals with higher neuropsychiatric 
PRS and emotional problems are less likely to remain in studies until adulthood which may have 
reduced power to detect associations between PRS and emotional problems (Martin et al., 2016, 
Wolke et al., 2009). Another consideration is that NCDS was included as a control sample in the PGC 
GWAS (Ripke et al., 2013, Schizophrenia Working Group of the Psychiatric Genomics Consortium, 
2014). Although this does not threaten the validity of the current investigation because it is a within
rather than between sample analysis, statistical power will have been reduced because NCDS was 
included as a control group in the original discovery investigation. Finally, although PRS are useful 
indicators of genetic liability (see Kendler, 2016), at present they explain very little phenotype 
variance in population traits – and are especially weak for MDD so the small effect sizes that we 
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observe are typical for this kind of work (e.g. Riglin et al., 2016). For example – adopting the 
approach used by Kendler (2016) individuals in the top 2.5% for schizophrenia PRS would have a 
roughly 20% increased risk of having an additional emotional problem symptom in mid-life, while 
individuals in the top 2.5% for MDD PRS would have a roughly 12% increased risk. This means PRS 
should be regarded as indicators of genetic liability rather than as predictors. These limitations 
highlight the need for further replications in population-based and patient studies but ones that assess 
developmental differences. 
The present study indicates that emotional problems in the general population show genetic 
overlap with schizophrenia and MDD but that childhood emotional problems may share more genetic 
risk with schizophrenia, while later emotional problems may also share genetic risk with MDD. These 
findings suggest that the genetic architecture of emotional problems may not be static across 
development, and that different liabilities could contribute to the manifestation of symptoms at 
different ages.  
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Table 1. Associations between schizophrenia and major depressive disorder polygenic risk scores 
(PRS) and emotional problems 
Emotional problems Schizophrenia risk alleles MDD risk alleles
OR (95% CI) p OR (95% CI) p
Age 7 1.09 (1.03-1.15) 0.003 1.03 (0.98-1.09) 0.228
Age 11 1.00 (0.95-1.06) 0.925 0.98 (0.93-1.04) 0.551
Age 16 1.09 (1.02-1.16) 0.012 0.98 (0.92-1.04) 0.450
Age 23 1.08 (1.01-1.13) 0.021 1.02 (0.97-1.08) 0.420
Age 33 1.07 (1.01-1.35) 0.027 1.06 (1.00-1.12) 0.048
Age 42 1.10 (1.05-1.17) <0.001 1.06 (1.00-1.11) 0.034
* Emotional problems measured by depression/anxiety items from the Rutter A scale at ages 7, 11 and 
16 years and from the Malaise Inventory at ages 23, 33 and 42 years.
1 
Supplementary Material 
Supplementary Table S1. Associations with sample retention (genotype data) 
OR (95% CI) p
Characteristics collected during pregnancy
Female sex 0.98 (0.90-1.06) 0.541
Region 1.00 (0.89-1.13) 0.950
Birth weight 1.00 (1.00-1.00) 0.565
Maternal age 1.00 (0.99-1.00) 0.997
Maternal marital status 1.15 (0.90-1.47) 0.259
Maternal education 0.91 (0.83-1.00) 0.056
Smoking in pregnancy 1.09 (1.00-1.19) 0.061
Social class 0.97 (0.87-1.08) 0.590
Emotional problems
Age 7 1.02 (0.97-1.06) 0.510
Age 11 1.01 (0.97-1.06) 0.652
Age 16 0.98 (0.93-1.04) 0.457
Age 23 0.97 (0.94-0.99) 0.014
Age 33 0.96 (0.94-0.99) 0.007
Age 42 0.98 (0.96-1.00) 0.024
Total N=9377. Region = Wales/Scotland vs. England; maternal marital status = married/stable union 
vs. unmarried/separated/widowed; maternal education = schooling after minimum leaving age; social 
class = husband’s social class I/II vs III/IV/V (Registrar General’s classification). 
2 
Supplementary Table S2. Malaise emotional items 
All depression/anxiety items Do you feel tired most of the time? Do you often feel miserable or depressed? Do you often get worried about things? Do you usually have great difficulty in falling or staying asleep? Do you usually wake unnecessarily early in the morning? Do you wear yourself out worrying about your health? Do you often suddenly become scared for no good reason? Are you scared to be alone when there are no friends near you? Are you frightened of going out alone or of meeting people? Are you constantly keyed up or jittery? Is your appetite poor?
Supplementary Table S3. Overlapping items  
Ages 7 and 11 years Age 16 years Ages 23, 33 and 42 years
Measure (Modified Rutter A scale) (Rutter A scale) (Malaise )
Depression item Is miserable or tearful. Often appears 
miserable, unhappy, 
tearful or distressed.
Do you often feel 
miserable or depressed?
Anxiety item Worries about many 
things.
Often worried, worries 
about many things.
Do you often get worried 
about things?
Coding Frequently = 2
Sometimes = 1
Never = 0
Certainly applies = 2
Applies somewhat = 1




Supplementary Table S4. Correlations between emotional problems at different ages 
1. 2. 3. 4. 5. 6. 7. 8. 9.
Primary outcome measures
1. Age 7 1
2. Age 11 0.389 1
3. Age 16 0.243 0.325 1
4. Age 23 0.085 0.105 0.184 1
5. Age 33 0.056 0.089 0.177 0.454 1
6. Age 42 0.083 0.094 0.163 0.414 0.517 1
Restricted items
7. Age 23 0.099 0.116 0.192 0.798 0.399 0.360 1
8. Age 33 0.048 0.093 0.186 0.397 0.778 0.423 0.416 1
9. Age 42 0.079 0.100 0.161 0.364 0.427 0.796 0.365 0.429 1
Spearman’s rho correlations. N=3558-5059 
Supplementary Table S5. Associations between polygenic risk scores and the restricted set of total 
emotional problems for each age  
Schizophrenia risk alleles MDD risk alleles
OR (95% CI) p OR (95% CI) p
Age 7 1.09 (1.03-1.15) 0.003 1.03 (0.98-1.09) 0.228
Age 11 1.00 (0.95-1.06) 0.925 0.98 (0.93-1.04) 0.551
Age 16 1.09 (1.02-1.16) 0.012 0.98 (0.92-1.04) 0.450
Age 23 1.08 (1.02-1.15) 0.013 1.06 (1.00-1.13) 0.066
Age 33 1.08 (1.01-1.15) 0.030 1.07 (1.01-1.14) 0.032
Age 42 1.11 (1.05-1.18) <0.001 1.03 (0.98-1.09) 0.215
MDD = Major Depressive Disorder.  
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Supplementary Table S6. Associations between polygenic risk scores and emotional problems for 
each age, using weight adjusting for biases associated with nonresponse 
Schizophrenia risk alleles MDD risk alleles
OR (95% CI) p OR (95% CI) p
Age 7 1.09 (1.02-1.15) 0.006 1.04 (0.99-1.11) 0.131
Age 11 1.00 (0.95-1.07) 0.874 0.98 (0.92-1.04) 0.486
Age 16 1.07 (1.00-1.14) 0.067 0.97 (0.91-1.04) 0.417
Age 23 1.08 (1.01-1.14) 0.021 1.03 (0.97-1.09) 0.343
Age 33 1.08 (1.00-1.15) 0.020 1.06 (1.00-1.13) 0.052
Age 42 1.10 (1.04-1.16) 0.002 1.05 (0.99-1.11) 0.090 
MDD = Major Depressive Disorder. Weights were estimated using logistic regression including 
variables assessed in pregnancy (sex, region, birth weight, maternal age, maternal marital status, 
maternal education, smoking in pregnancy and social class: all with less than 10% missing values) 
and polygenic risk scores (population stratification components and batch), i.e. comparing those with 
data to those without. Separate weights generated for each time point. The top 1% of weights were 
trimmed to the next highest value to reduce the impact of extreme outliers. 
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Supplementary Figure S1. Associations between polygenic risk scores and emotional problems, 
using a range of p-value thresholds from the discovery sample
a) Schizophrenia risk alleles
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Supplementary Figure S2. Frequencies for the restricted set of total emotional problems by age 
NB. Ages 7 and 11 (modified Rutter scale) and 16 years (Rutter scale) are scored 0-4, ages 23, 33 and 
42 years (Malaise) are scored 0-2. 
Supplementary Figure S3. Polygenic risk scores (PRS) for emotional problems persistence/age-at-
onset across childhood and adulthood 
NB. Estimated means at mean covariate values. MDD = Major Depressive Disorder. RRR=relative 
risk ratio (with 95% confidence intervals) from multinomial regression for elevated emotional 
symptoms (top decile) in childhood only (age 7 or 11 years, but not later), in adulthood only (ages 33 
or 42, but not earlier) and persistently elevated scores (age 7 or 11 and age 33, 42 or 44), compared to 
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